Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer-Reference-Cited by-同舟云学术

Diagnostic Efficacy of 68 Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer

Published:2016-05 Issue:5 Volume:195 Page:1436-1443
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Maurer Tobias¹,Gschwend Jürgen E.¹,Rauscher Isabel²,Souvatzoglou Michael²,Haller Bernhard³,Weirich Gregor⁴,Wester Hans-Jürgen⁵,Heck Matthias¹,Kübler Hubert¹,Beer Ambros J.²⁶,Schwaiger Markus²,Eiber Matthias²

Affiliation:

1. Department of Urology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany

2. Department of Nuclear Medicine, Technische Universität München, Klinikum rechts der Isar, Munich, Germany

3. Institute of Medical Statistics and Epidemiology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany

4. Institute of Pathology, Technische Universität München, Klinikum rechts der Isar, Munich, Germany

5. Department of Pharmaceutical Radiochemistry, Technische Universität München, Klinikum rechts der Isar, Munich, Germany

6. Department of Nuclear Medicine, University of Ulm, Ulm, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Prostate Cancer,2015

2. The diagnostic accuracy of CT and MRI in the staging of pelvic lymph nodes in patients with prostate cancer: a meta-analysis;Hovels;Clin Radiol,2008

3. MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study;Heesakkers;Lancet Oncol,2008

4. PET/MR in prostate cancer: technical aspects and potential diagnostic value;Souvatzoglou;Eur J Nucl Med Mol Imaging,2013

5. Comparison of integrated whole-body [11C]choline PET/MR with PET/CT in patients with prostate cancer;Souvatzoglou;Eur J Nucl Med Mol Imaging,2013

Cited by 673 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Brain Metastatic Prostate Adenocarcinoma: Avoiding Mistaken Identities;Cureus;2024-09-12

2. [18F]AlF-PSMA-11 PET in diagnosing prostate cancer: a head-to-head comparison with [68Ga]Ga-PSMA-11 PET and an exploration of dual-phase scanning;EJNMMI Reports;2024-09-09

3. The Relationship between D’Amico and ISUP Risk Classifications and 68Ga-PSMA PET/CT SUVmax Values in Newly Diagnosed Prostate Cancers;Current Oncology;2024-09-08

4. Volumetric Modulated Arc Therapy for High-Risk and Very High-Risk Locoregional Prostate Cancer in the Modern Era: Real-World Experience from an Asian Cohort;Cancers;2024-08-25

5. Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-31